Reading time: 1 minutes

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

stent-403500-edited.png

“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."

The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients.  The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here

LEARN ABOUT PULSARA

ARTICLE CATEGORIES: Stroke
Share This Article    
Brittney Nelson, BSN, RN, SCRN

Brittney Nelson, BSN, RN, SCRN

Brittney is a registered nurse and SCRN who served as the Stroke Coordinator at Trinity Mother Frances Hospital. Her passion for stroke patients and the acute stroke care process led her to her current position as Implementation Specialist at Pulsara.

Read more articles by Brittney Nelson, BSN, RN, SCRN

Get instant blog updates from the Pulsara team sent directly to your inbox!

The Future of Healthcare Communication: Connected Teams

Connect Yours Now

Schedule a Demo